1887

Abstract

Cytomegalovirus (CMV) infection during pregnancy may lead to adverse pregnancy outcomes and permanent neurological disabilities in infants infected in utero. Congenital CMV disease of the foetus and neonate results from both direct viral cytopathic damage and indirect effects through placental dysfunction. Infection specifically alters Wnt signalling, an essential pathway involved in trophoblast migration and placental development. We examined CMV regulation of trophoblast migration. This virus controls expression of Wnt-binding receptor tyrosine kinase ROR2, but not alternate receptor tyrosine kinases ROR1 or RYK. Ectopic expression of ROR2 reduced Wnt5a-induced trophoblast migration, whilst overexpression of ROR1 or RYK did not affect trophoblast migration. CMV infection increased ROR2 protein expression in trophoblasts, with no effect on ROR1 and RYK expression. These data further support the proposal that specific inhibition of this mechanism may be a target for therapeutic intervention to reduce placental damage and consequent foetal disease due to congenital CMV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001179
2018-11-15
2019-12-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/100/1/99.html?itemId=/content/journal/jgv/10.1099/jgv.0.001179&mimeType=html&fmt=ahah

References

  1. Mcmullan BJ, Palasanthiran P, Jones CA, Hall BM, Robertson PW et al. Congenital cytomegalovirus-time to diagnosis, management and clinical sequelae in Australia: opportunities for earlier identification. Med J Aust 2011;194:625–629
    [Google Scholar]
  2. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013;26:86–102 [CrossRef][PubMed]
    [Google Scholar]
  3. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253–276 [CrossRef][PubMed]
    [Google Scholar]
  4. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355–363 [CrossRef][PubMed]
    [Google Scholar]
  5. Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. The Journal of Infectious Diseases 2011;203:1526–1533 [CrossRef]
    [Google Scholar]
  6. Pereira L, Petitt M, Fong A, Tsuge M, Tabata T et al. Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis 2014;209:1573–1584 [CrossRef][PubMed]
    [Google Scholar]
  7. Williams EJ, Embleton ND, Clark JE, Bythell M, Ward Platt MP et al. Viral infections: contributions to late fetal death, stillbirth, and infant death. J Pediatr 2013;163:424–428 [CrossRef][PubMed]
    [Google Scholar]
  8. Lorenzoni F, Lunardi S, Liumbruno A, Ferri G, Madrigali V et al. Neonatal screening for congenital cytomegalovirus infection in preterm and small for gestational age infants. The Journal of Maternal-Fetal & Neonatal Medicine 2014;27:1589–1593 [CrossRef]
    [Google Scholar]
  9. Xie F, Hu Y, Magee LA, Money DM, Patrick DM et al. An association between cytomegalovirus infection and pre-eclampsia: a case–control study and data synthesis. Acta Obstetricia et Gynecologica Scandinavica 2010;89:1162–1167 [CrossRef]
    [Google Scholar]
  10. Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clinical Infectious Diseases 2011;52:e11e13 [CrossRef]
    [Google Scholar]
  11. Puhakka L, Renko M, Helminen M, Peltola V, Heiskanen-Kosma T et al. Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection – register-based study from Finland. Infectious Diseases 2017;49:445–453 [CrossRef]
    [Google Scholar]
  12. Ornoy A, Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006;21:399–409 [CrossRef][PubMed]
    [Google Scholar]
  13. Simonazzi G, Curti A, Cervi F, Gabrielli L, Contoli M et al. Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience. Fetal Diagn Ther 2018;43:138–142 [CrossRef][PubMed]
    [Google Scholar]
  14. Mussi-Pinhata MM, Yamamoto AY, Moura Brito RM, de Lima Isaac M, de Carvalho E Oliveira PF et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 2009;49:522–528 [CrossRef][PubMed]
    [Google Scholar]
  15. Gaytant MA, Rours GI, Steegers EA, Galama JM, Semmekrot BA. Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature. Eur J Pediatr 2003;162:248–253 [CrossRef][PubMed]
    [Google Scholar]
  16. Zalel Y, Gilboa Y, Berkenshtat M, Yoeli R, Auslander R et al. Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Ultrasound Obstet Gynecol 2008;31:417–420 [CrossRef][PubMed]
    [Google Scholar]
  17. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999;104:55–60 [CrossRef][PubMed]
    [Google Scholar]
  18. Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 2006;148:332–336 [CrossRef][PubMed]
    [Google Scholar]
  19. Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 2017;17:e177e188 [CrossRef][PubMed]
    [Google Scholar]
  20. Cheeran MC, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009;22:99–126 [CrossRef][PubMed]
    [Google Scholar]
  21. Gabrielli L, Bonasoni MP, Lazzarotto T, Lega S, Santini D et al. Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 2009;46 Suppl 4:S16–S21 [CrossRef][PubMed]
    [Google Scholar]
  22. Gabrielli L, Bonasoni MP, Santini D, Piccirilli G, Chiereghin A et al. Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect 2012;18:E419E427 [CrossRef][PubMed]
    [Google Scholar]
  23. Hamilton ST, Scott G, Naing Z, Iwasenko J, Hall B et al. Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One 2012;7:e52899 [CrossRef][PubMed]
    [Google Scholar]
  24. Weisblum Y, Panet A, Zakay-Rones Z, Vitenshtein A, Haimov-Kochman R et al. Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface. Virology 2015;485:289–296 [CrossRef][PubMed]
    [Google Scholar]
  25. Pereira L, Tabata T, Petitt M, Fang-Hoover J. Congenital cytomegalovirus infection undermines early development and functions of the human placenta. Placenta 2017;59 Suppl 1:S8–S16 [CrossRef][PubMed]
    [Google Scholar]
  26. Maidji E, Nigro G, Tabata T, Mcdonagh S, Nozawa N et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 2010;177:1298–1310 [CrossRef][PubMed]
    [Google Scholar]
  27. Garcia AG, Fonseca EF, Marques RL, Lobato YY. Placental morphology in cytomegalovirus infection. Placenta 1989;10:1–18 [CrossRef][PubMed]
    [Google Scholar]
  28. Rauwel B, Mariamé B, Martin H, Nielsen R, Allart S et al. Activation of peroxisome proliferator-activated receptor gamma by human cytomegalovirus for de novo replication impairs migration and invasiveness of cytotrophoblasts from early placentas. J Virol 2010;84:2946–2954 [CrossRef][PubMed]
    [Google Scholar]
  29. Warner JA, Zwezdaryk KJ, Day B, Sullivan DE, Pridjian G et al. Human cytomegalovirus infection inhibits CXCL12- mediated migration and invasion of human extravillous cytotrophoblasts. Virol J 2012;9:255 [CrossRef][PubMed]
    [Google Scholar]
  30. Hamilton ST, Scott GM, Naing Z, Rawlinson WD. Human cytomegalovirus directly modulates expression of chemokine CCL2 (MCP-1) during viral replication. J Gen Virol 2013;94:2495–2503 [CrossRef][PubMed]
    [Google Scholar]
  31. Chou D, Ma Y, Zhang J, Mcgrath C, Parry S. Cytomegalovirus infection of trophoblast cells elicits an inflammatory response: a possible mechanism of placental dysfunction. Am J Obstet Gynecol 2006;194:535–541 [CrossRef][PubMed]
    [Google Scholar]
  32. Kovács IJ, Hegedus K, Pál A, Pusztai R. Production of proinflammatory cytokines by syncytiotrophoblasts infected with human cytomegalovirus isolates. Placenta 2007;28:620–623 [CrossRef][PubMed]
    [Google Scholar]
  33. Schleiss MR, Aronow BJ, Handwerger S. Cytomegalovirus infection of human syncytiotrophoblast cells strongly interferes with expression of genes involved in placental differentiation and tissue integrity. Pediatr Res 2007;61:565–571 [CrossRef][PubMed]
    [Google Scholar]
  34. Tao L, Suhua C, Juanjuan C, Zongzhi Y, Juan X et al. In vitro study on human cytomegalovirus affecting early pregnancy villous EVT's invasion function. Virol J 2011;8:114 [CrossRef][PubMed]
    [Google Scholar]
  35. Scott GM, Chow SS, Craig ME, Pang CN, Hall B et al. Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 2012;205:1305–1310 [CrossRef][PubMed]
    [Google Scholar]
  36. Angelova M, Zwezdaryk K, Ferris M, Shan B, Morris CA et al. Human cytomegalovirus infection dysregulates the canonical Wnt/beta-catenin signaling pathway. PLoS Pathogens, Research Support, N. I.H., Extramural Research Support, Non-U.S. Gov't 2012;8:e1002959
    [Google Scholar]
  37. van Zuylen WJ, Ford CE, Wong DD, Rawlinson WD. Human cytomegalovirus modulates expression of noncanonical wnt receptor ror2 to alter trophoblast migration. J Virol 2016;90:1108–1115 [CrossRef][PubMed]
    [Google Scholar]
  38. Sonderegger S, Husslein H, Leisser C, Knöfler M. Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 2007;28 Suppl A:S97–S102 [CrossRef][PubMed]
    [Google Scholar]
  39. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell 2012;149:1192–1205 [CrossRef][PubMed]
    [Google Scholar]
  40. Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 2012;13:767–779 [CrossRef][PubMed]
    [Google Scholar]
  41. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 2006;4:e115 [CrossRef][PubMed]
    [Google Scholar]
  42. Janovská P, Bryja V. Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas. Br J Pharmacol 2017;174:4701–4715 [CrossRef][PubMed]
    [Google Scholar]
  43. Henry C, Quadir A, Hawkins NJ, Jary E, Llamosas E et al. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling. J Cancer Res Clin Oncol 2015;141:243–254 [CrossRef][PubMed]
    [Google Scholar]
  44. Henry C, Hacker N, Ford C. Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis. Oncotarget 2017;8:112727–112738 [CrossRef][PubMed]
    [Google Scholar]
  45. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M et al. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 2009;28:3197–3208 [CrossRef][PubMed]
    [Google Scholar]
  46. Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010;29:2036–2046 [CrossRef][PubMed]
    [Google Scholar]
  47. Habu M, Koyama H, Kishida M, Kamino M, Iijima M et al. Ryk is essential for Wnt-5a-dependent invasiveness in human glioma. J Biochem 2014;156:29–38 [CrossRef][PubMed]
    [Google Scholar]
  48. Feng HC, Choy MY, Deng W, Wong HL, Lau WM et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig 2005;12:e21e32 [CrossRef][PubMed]
    [Google Scholar]
  49. Roy JP, Halford MM, Stacker SA. The biochemistry, signalling and disease relevance of RYK and other WNT-binding receptor tyrosine kinases. Growth Factors 2018;36:15–40 [CrossRef][PubMed]
    [Google Scholar]
  50. Fisher SJ. Why is placentation abnormal in preeclampsia?. Am J Obstet Gynecol 2015;213:S115–S122 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001179
Loading
/content/journal/jgv/10.1099/jgv.0.001179
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error